|
 The incidents come as advisers to the CDC are set to meet on Friday
to consider whether it is safe to resume injections of the
single-dose vaccine, while senior health officials prepare for a
green light.
"It's important to remember that just because something is reported,
it doesn't necessarily mean it was caused by, or linked to, the
vaccine," said Imelda Garcia of the Texas health agency, according
to the Austin American-Statesman newspaper.
The CDC notified Oregon about the incident on Tuesday and Texas on
Wednesday, the two states' health officials said.
The Oregon woman, who is in her 50s, received the vaccine before the
pause order on its use was issued, the state's health authority said
in a statement. (https://bit.ly/32GLvYQ)
She developed "a rare but serious blood clot within two weeks
following vaccination," seen in combination with very low platelets,
the Oregon Health Authority added.
It warned that blame could not be assigned until its investigation
was complete.
[to top of second column] |
 Separately, a woman in Texas
who received J&J's vaccine has been hospitalised
for symptoms similar to those of six people who
recently suffered blood clots after taking the
shot in the United States, a Texas health agency
spokesman said. Both states
confirmed that the new cases were separate from the previous six
incidents.
Last week, U.S. health agencies recommended a pause in the use of
the J&J vaccine over the six rare cases of blood clots, among
roughly 7 million people who have received the shot.
On Tuesday, the European Medicines Agency (EMA) said it found a
possible link between J&J's vaccine and rare blood clotting issues
in adults who got doses in the United States, but added that the
benefits of the shot outweighed the risks.
(Reporting by Kanishka Singh and Shubham Kalia in Bengaluru; Editing
by Ana Nicolaci da Costa and Clarence Fernandez)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |
